Gilead Sciences | GILD - 株式

株価
137.21
毎日の変更
-3.90 -2.76%
毎月
-8.42%
毎年
28.14%
Q1 予測
133.09




株式 変化する 日付
AbbVie USD 4.95B 13M 2025-12
Agios Pharmaceuticals USD 32.92M 886K 2025-12
ALKERMES USD 196.62M 5.63M 2025-12
Alnylam Pharmaceuticals USD 82.72M 7.34M 2025-12
Amgen USD 6.22B 121M 2025-12
Biogen USD 2.17B 41.3M 2025-12
BioMarin Pharmaceutical USD 1.3B 83.29M 2025-12
Bristol-Myers Squibb USD 2.76B 21M 2025-09
Coherus Biosciences USD 3.17M 1.12M 2025-12
Eli Lilly USD 13.74B 1.56B 2025-12
Gilead Sciences USD 1.78B 40M 2025-09
GlaxoSmithKline GBP 6.12B 46M 2025-09
Glaxosmithkline GBP 6.12B 46M 2025-09
Incyte USD 101.06M 17.61M 2025-12
J&J USD 14.19B 45M 2025-12
Merck USD 6.44B 157M 2025-09
Moderna USD 332M 92M 2025-09
Neurocrine Biosciences USD 69M 300K 2025-12
Novartis USD 6.42B 114M 2025-09
Pfizer USD 11.47B 201M 2025-09
PTC Therapeutics USD 79.65M 26.96M 2025-12
Puma Biotechnology USD 9.48M 885K 2025-09
Regeneron Pharmaceuticals USD 3.2B 53.6M 2025-12
Sanofi EUR 22.69B 1.81B 2025-12
Sarepta Therapeutics USD 914.74M 162.42M 2025-12
United Therapeutics USD 183.1M 6.6M 2025-12
Vertex Pharmaceuticals USD 1.69B 60M 2025-12